ProShares Ultra Nasdaq Biotechnology
BIB
NASDAQ107.74
USD
-2.10
- -
Total Valuation
ProShares Ultra Nasdaq Biotechnology carries a market capitalization of 89.43M, placing it among publicly traded companies globally.
| Market Cap | 89.43M |
| Enterprise Value | N/A |
Stock Price Statistics
ProShares Ultra Nasdaq Biotechnology's stock has gained approximately 125.77598% over the past 52 weeks. The 50-day moving average sits at 85.70, while the 200-day moving average is 79.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | 125.77598% |
| 50-Day Moving Average | 85.70 |
| 200-Day Moving Average | 79.77 |
| Average Volume (20 Days) | N/A |
Stock Splits
ProShares Ultra Nasdaq Biotechnology's most recent stock split took place on May 20, 2015 with a 1:2 split ratio.
| Last Split Date | 5/20/2015 |
| Split Ratio | 1:2 |